Prevalence of contraindications and conditions for precaution for prasugrel administration in a real world acute coronary syndrome population-Reference-Cited by-同舟云学术

Prevalence of contraindications and conditions for precaution for prasugrel administration in a real world acute coronary syndrome population

Published:2011-06-17 Issue:3 Volume:32 Page:328-333
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Alexopoulos Dimitrios,Xanthopoulou Ioanna,Mylona Panagiota,Perperis Angelos,Panagiotou Aggeliki,Dimitropoulos Gerasimos,Tsigkas Grigorios,Hahalis George,Davlouros Periklis

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-011-0610-9.pdf

Reference15 articles.

1. Brandt JT, Payne CD, Wiviott SD et al (2007) A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. Am Heart J 153:66.e9–66.e16

2. Jakubowski JA, Matsushima N, Asai F et al (2007) A multiple dose study of prasugrel (CS-747), a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans. Br J Clin Pharmacol 63:421–430

3. Wallentin L, Varenhorst C, James S et al (2008) Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. Eur Heart J 29:21–30

4. Wiviott SD, Braunwald E, McCabe CH et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001–2015

5. Prasugrel prescribing information. Center for drug evaluation and research. www.accessdata.fda.gov/drugsatfda_docs/label/2009/022307s000lbl.pdf . Access date 23/12/2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening of Synthetic Heterocyclic Compounds as Antiplatelet Drugs;Medicinal Chemistry;2022-05

2. Comparison of Antiplatelet Effects of Phenol Derivatives in Humans;Biomolecules;2022-01-12

3. Synthesis of 3,3-dimethyl-6-oxopyrano[3,4-c]pyridines and their antiplatelet and vasodilatory activity;Journal of Pharmacy and Pharmacology;2021-06-09

4. Anticoagulant and Antiplatelet Therapy;Pharmacology and Physiology for Anesthesia;2019

5. Platelet pathophysiology, pharmacology, and function in coronary artery disease;Coronary Artery Disease;2017-11